Citation

A M Stek, C Hu, E V Capparelli, D T Holland, S K Burchett, M E Smith, E C Sheeran, W T Shearer, I Febo, M Mirochnick, J S Read, B M Best. Pharmacokinetics and safety of the new 625 mg nelfinavir tablet formulation during pregnancy and postpartum.. HIV Medicine. 2008. 9: 875-82. PMID: 18795962

Citation

J Hitti, PACTG P1022 Study Team, A Stek, C Hu, S K Burchett, B Best, E Smith, J S Read, H Watts, S Nachman, E M Thorpe Jr, S A Spector, E Jimenez, W T Shearer, M Foca, E V Capparelli, M Mirochnick, F Aweeka, PACTG 1026S Study Team. Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokinetics. HIV Medicine. 2008. 9: 214-20. PMID: 18366444

Citation

Alice M Stek, Edmund Capparelli, ChengCheng Hu, Sandra K Burchett, Diane T Holland, Elizabeth Smith, Sreedhar Gaddipati, Jennifer S Read, PACTG 1026s Study Team, Mark Mirochnick, Brookie M Best. Lopinavir exposure with an increased dose during pregnancy. Journal of Acquired Immune Deficiency Syndromes. 2008. 49: 485-91. PMID: 18989231

Citation

Edmund V Capparelli, Alice Stek, Sandra K Burchett, Diane T Holland, Jennifer S Read, Elizabeth Smith, Chengcheng Hu, Stephen A Spector, James D Connor, PACTG P1026s Study Team, Brookie M. Best, Mark Mirochnick. Impact of pregnancy on abacavir pharmacokinetics. AIDS. 2006. 20: 553-560. PMID: 16470119

Citation

Edmund Capparelli, Brookie M. Best, ChengCheng Hu, Sandra K. Burchett, Carol Elgie, Diane T. Holland, Elizabeth Smith, Ruth Tuomala, Amanda Cotter, Jennifer S. Read, Alice M. Stek, Mark Mirochnick. Reduced lopinavir exposure during pregnancy.. AIDS. 2006. 20: 1931 - 1939. PMID: 16988514